Empresa Harpoon Therapeutics, Inc.
Acciones
HARP
US41358P2056
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 53
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/10/18 |
Frank Lanza
DFI | Director of Finance/CFO | 62 | 01/04/19 |
Chatan Charan
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Holger Wesche
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/10/18 |
Luke Walker
CTO | Chief Tech/Sci/R&D Officer | - | 03/10/22 |
Haibo Wang
PRN | Corporate Officer/Principal | - | 01/08/23 |
Banmeet Anand
PRN | Corporate Officer/Principal | - | 06/07/22 |
Wendy Chang
HRO | Human Resources Officer | - | 06/07/22 |
Rachael Lester
PRN | Corporate Officer/Principal | - | 01/09/17 |
James B. Bucher
LAW | General Counsel | 59 | 26/12 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/10/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 21 397 205 | 16 465 638 ( 76,95 %) | 0 | 76,95 % |
Información de la empresa
Harpoon Therapeutics, Inc.
611 Gateway Boulevard Suite 400
94080, South San Francisco
+650 443 7400
http://www.harpoontx.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,54 % | 105 mil M | |
+3,58 % | 97,5 mil M | |
+1,86 % | 22,19 mil M | |
-16,63 % | 21,33 mil M | |
-8,49 % | 18,68 mil M | |
-42,33 % | 16,6 mil M | |
-20,40 % | 14,52 mil M | |
+5,58 % | 14,09 mil M | |
+28,23 % | 10,99 mil M |